Effect of Capecitabine Combined with Oxaliplatin in the Treatment of Colon Cancer Based on CT Image Analysis
Objective:To analyze the clinical efficacy of capecitabine combined with oxaliplatin in the treatment of colon cancer based on CT images.Methods:All patients with non-metastatic colon cancer who underwent radical resection and chemotherapy in our hospital from January 2018 to January 2021 were selected as the research objects.They were divided into control group and experimental group by random number table method,with 31 cases in each group.The control group was given oxaliplatin,and the experimental group was given oxaliplatin combined with capecitabine.Compared with the pathological results,the diagnostic value of CT was analyzed,and the CT parameters and side effects of the two groups were compared.Results:There was no significant difference between CT and pathological diagnosis(P>0.05).After treatment,the levels of △CT40KeV AP(HU),ICAP,ICVP,λAP and NICAP in the experimental group were lower than those in the control group(P<0.05).The incidence of leukopenia,anemia,thrombocytopenia,nausea and vomiting,ALT/AST,proteinuria,creatinine,hematuria and alopecia between the two groups were not statistically significant(P>0.05).Conclusion:Multi-parameter quantitative analysis of CT has certain clinical value in evaluating the clinical efficacy of capecitabine combined with oxaliplatin in the treatment of colon cancer,and can provide reference indexes and values for clinical monitoring of tumor treatment efficacy.
NETL
NSTL
万方数据
